Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for WHWK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 182.92M
March 31, 2026 116.18M
December 31, 2025 136.31M
September 30, 2025 157.17M
June 30, 2025 172.07M
March 31, 2025 221.73M
December 31, 2024 52.48M
September 30, 2024 68.87M
June 30, 2024 78.79M
March 31, 2024 90.46M
December 31, 2023 105.20M
September 30, 2023 118.20M
June 30, 2023 131.42M
March 31, 2023 145.99M
December 31, 2022 158.38M
September 30, 2022 169.11M
June 30, 2022 108.73M
March 31, 2022 124.63M
December 31, 2021 136.41M
Date Value
September 30, 2021 150.92M
June 30, 2021 35.22M
March 31, 2021 39.03M
December 31, 2020 -12.43M
September 30, 2020 47.32M
June 30, 2020 42.60M
March 31, 2020 33.01M
December 31, 2019 36.54M
September 30, 2019 41.71M
June 30, 2019 45.72M
March 31, 2019 50.80M
December 31, 2018 58.67M
September 30, 2018 66.52M
June 30, 2018 47.91M
March 31, 2018 11.11M
December 31, 2017 17.44M
September 30, 2017 23.42M
June 30, 2017 27.94M
March 31, 2017 33.31M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -199.08M
Amgen, Inc. 11.69B
Anika Therapeutics, Inc. 137.28M
BioCryst Pharmaceuticals, Inc. -454.29M
Imunon, Inc. 4.189M

Shareholders Equity (Quarterly) Related Metrics